Evidence map›Paper›PMID 20541998›Full record

ArticleMolecular cell2010

Multiple Rad5 activities mediate sister chromatid recombination to bypass DNA damage at stalled replication forks.

Eugen C Minca, David Kowalski

Open access · bronzeAbstract read
In one paragraph

Article in Molecular cell, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 67 papers.

0numbers the graph read from it
0cells of the map it votes in
67citing papers in PubMed
3.8field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

67 citing papers in PubMed, 116 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Review
  14. Article
  15. Article
  16. Review
  17. SUMOylation of PCNA by PIAS1 and PIAS4 promotes template switch in the chicken and human B cell lines.Proceedings of the National Academy of Sciences of the United States of America · 2018
    Article
  18. Review
  19. Article
  20. Article

7 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Eugen C MincaDepartment of Cancer Biology, Roswell Park Cancer Institute, Buffalo, NY 14263, USA.
David Kowalski
Roswell Park Comprehensive Cancer Center · US

Funding

Two-Spirit Films in Indigenous Cancer HealthP30CA016056 · NCI · ROSWELL PARK CANCER INSTITUTE CORP · PI MARK G FRATTINI · 1985 to 2026
$116.6M
STRUCTURE AND ACTIVITY OF DNA REPLICATION ORIGINSR01GM030614 · NIGMS · ROSWELL PARK CANCER INSTITUTE CORP · PI KOWALSKI, DAVID · 1985 to 2004
$1.4M
NCI NIH HHS CA016056NIGMS NIH HHS GM30614NIGMS NIH HHS R01 GM030614
6 · The paper itself

Abstract

DNA damage that blocks replication is bypassed in order to complete chromosome duplication and preserve cell viability and genome stability. Rad5, a PCNA polyubiquitin ligase and DNA-dependent ATPase in yeast, is orthologous to putative tumor suppressors and controls error-free damage bypass by an unknown mechanism. To identify the mechanism in vivo, we investigated the roles of Rad5 and analyzed the DNA structures that form during damage bypass at site-specific stalled forks present at replication origins. Rad5 mediated the formation of recombination-dependent, X-shaped DNA structures containing Holliday junctions between sister chromatids. Mutants lacking these damage-induced chromatid junctions were defective in resolving stalled forks, restarting replication, and completing chromosome duplication. Rad5 polyubiquitin ligase and ATPase domains both contributed to replication fork recombination. Our results indicate that multiple activities of Rad5 function coordinately with homologous recombination factors to enable replication template switch events that join sister chromatids at stalled forks and bypass DNA damage.

Indexed as

ChromatidsDNA DamageDNA ReplicationRecombination, GeneticAntineoplastic Agents, AlkylatingBenzofuransCyclohexanecarboxylic AcidsCyclohexenesDNADNA, CruciformDNA HelicasesDuocarmycinsIndolesNucleic Acid ConformationSaccharomyces cerevisiaeSaccharomyces cerevisiae ProteinsadozelesinAntineoplastic Agents, AlkylatingBenzofuransCyclohexanecarboxylic AcidsCyclohexenesDNADNA, CruciformDNA HelicasesDuocarmycinsIndolesRAD5 protein, S cerevisiaeSaccharomyces cerevisiae Proteins

Identifiers

PMID20541998
PMCPMC2887677
OpenAlexW2069894032

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.